ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,271,818 | -44.4% | 2,311,077 | -0.3% | 0.02% | -41.9% |
| Q2 2023 | $22,086,166 | -12.9% | 2,317,541 | +0.5% | 0.04% | -20.4% |
| Q1 2023 | $25,358,696 | +690.5% | 2,305,336 | +1273.7% | 0.05% | +671.4% |
| Q3 2022 | $3,208,000 | +676.8% | 167,816 | +1008.6% | 0.01% | +250.0% |
| Q2 2021 | $413,000 | -91.6% | 15,138 | -91.1% | 0.00% | -90.9% |
| Q1 2021 | $4,903,000 | +120.7% | 169,487 | +114.6% | 0.02% | +83.3% |
| Q4 2020 | $2,222,000 | – | 78,973 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |